径向动脉与隐静脉联合双侧胸廓内动脉对远期生存的影响:倾向评分分析
本研究回顾性分析660例三支血管冠心病患者,接受双侧胸廓内动脉(BIMA)联合径向动脉(RA,n=206)或隐静脉(SV,n=454)移植,倾向评分匹配后得到190对。匹配人群中,两组院内死亡率均为1.1%(P > .99),中位随访9.2年,5年、10年、15年生存率在BIMA+RA组为94.8±1.7%、83.7±3.1%、78.6±3.9%,BIMA+SV组为96.2±1.4%、85.1±2.9%、80.4±3.6%(分层log-rank P = .78)。Cox回归显示RA联合BIMA未影响晚期死亡率(倾向评分调整HR 1.05,95%CI 0.62-1.79,P = .83)。结论:在三支血管冠心病患者中,RA作为第三根动脉桥未带来远期生存获益。
要点
- BIMA+RA与BIMA+SV两组远期生存无显著差异(P = .78)。
- 倾向评分调整后RA联合BIMA未影响晚期死亡率(HR 1.05,95%CI 0.62-1.79)。
- 研究人群相对较小,结论需谨慎解读。
核心结论
- 在三支血管冠心病患者中,RA作为第三根动脉桥联合BIMA未 confer 远期生存获益。
主要发现
- 匹配人群中院内死亡4例(1%),BIMA+RA组2例(1.1%),BIMA+SV组2例(1.1%),P > .99。
- 中位随访9.2年(IQR 5.6-13年),最长18.5年,两组远期生存无显著差异。
- 5年、10年、15年生存率BIMA+RA组分别为94.8±1.7%、83.7±3.1%、78.6±3.9%,BIMA+SV组分别为96.2±1.4%、85.1±2.9%、80.4±3.6%(分层log-rank P = .78)。
- Cox回归显示RA联合BIMA未影响晚期死亡率(倾向评分调整HR 1.05,95%CI 0.62-1.79,P = .83)。
临床怎么用
- 对于三支血管冠心病患者,选择RA或SV作为BIMA之外的第三根桥血管时,远期生存获益无显著差异。
局限性
- 研究人群相对较小(660例,匹配后190对)。
- 为回顾性分析,可能存在未测量的混杂因素。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Long-term survival benefits of full arterial revascularization with radial artery (RA) used in addition to bilateral internal mammary arteries (BIMA) compared with saphenous vein (SV) used in addition to BIMA has not been clearly defined. METHODS: We retrospectively analyzed 660 3-vessel coronary artery disease subjects who received BIMA in addition to either RA (n = 206) or SV (n = 454) grafting in a period between June 1999 and November 2017. After propensity score matching, we obtained 190 matched pairs for analysis. RESULTS: In the matched population, in-hospital mortality occurred in 4 patients (1%), with 2 deaths (1.1%) in the BIMA + RA group and 2 deaths (1.1%) in BIMA + SV group (P > .99). The median follow-up time was 9.2 years (interquartile range, 5.6-13 years) with a maximum follow-up time of 18.5 years. There was not a significant difference in long-term survival between the 2 groups over the follow-up period. Survival at 5, 10, and 15 years were 94.8 ± 1.7%, 83.7 ± 3.1%, and 78.6 ± 3.9% in the BIMA + RA group and 96.2 ± 1.4%, 85.1 ± 2.9%, and 80.4 ± 3.6% in the BIMA + SV group (stratified log-rank P = .78). Cox proportional hazard regression model was used to estimate that the use of RA in addition to BIMA did not affect the late mortality (propensity score adjusted hazard ratio, 1.05; 95% confidence interval, 0.62-1.79; P = .83). CONCLUSIONS: In a relatively small population of triple-vessel coronary artery disease, the use of RA as a third arterial conduit with BIMA did not confer a long-term survival benefit.
引用
- Formica F, D'Alessandro S, Singh G, et al. The impact of the radial artery or the saphenous vein in addition to the bilateral internal mammary arteries on late survival: A propensity score analysis. J Thorac Cardiovasc Surg. 2019. PMID: 30745048. doi:10.1016/j.jtcvs.2018.12.078
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。